Asia Newswire and Press release service
About Us | Contact Us


Asia News & Press Release Distribution

Home | News Headlines | Press Release Distribution

Unlimited Press Release Distribution

Unlimited press release service

News Media

Asia One
Asia Correspondent
Asian Image
Asia Times
Asia Today
CNN Asia
BBC Asia
Channel News Asia
Financial Times
India Express
Weird Asia News
Digi Times
Japan Times
The Chosun Ilbo, Korea
Today Online
Tech Asia
Telecom Asia
The Economist, Asia
The WSJ, Asia
The Straits Times
Yahoo Asia
Yohap News Agency

Asia Newsire: Press releases on Asia

Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market to Grow at a CAGR of 4.85% During Forecast 2016-2020

(AsiaNewsWire.Net, August 10, 2016 ) Technavio Announces the Publication of its Research Report – Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020
Technavio recognizes the following companies as the key players in the global chronic obstructive pulmonary disease (COPD) drugs market: AstraZeneca, Boehringer Ingelheim, Merck, and Novartis.

Other Prominent Vendors in the market are: Ache Laboratorios Farmaceuticos, Almirall, Aquinox Pharmaceuticals, Ario Pharma, Asmacure, Astellas Pharma, BioMarck Pharmaceuticals, Chiesi Farmaceutici, Cytokinetics, F. Hoffmann-La Roche, Gilead Sciences, Innoviva, Invion, MediciNova, Mereo BioPharma, Mylan, Orion Corporation, Palobiofarma, Pearl Therapeutics, Pharmaxis, Prosonix, Pulmagen Therapeutics, RespiVert, SolAeroMed, Sunovion Pharmaceuticals, Theravance Biopharma, Theron Pharmaceuticals, Verona Pharma, Xention , Yungjin Pharm, and ZAI Lab.

Browse full report with TOC@

Commenting on the report, an analyst from Technavio’s team said: “Innovative technologies for drug delivery will be one of the key trends for market growth. Vendors are investing heavily in R&D activities to design and develop innovative inhalers and nebulizers that are compact, portable, patient-friendly, and provide accurate results. The high efficiency of these devices also helps reduce the residual drug volume in the them when compared to other types of nebulizers. The advances in inhalers such as sensors, and the use of smartphone and tablets that can track and record the drug treatment dose have resulted in providing an interface between the physicians and patients.”

According to the report, increase in smoking prevalence will be the key driver for market growth. Tobacco smoking is considered to be the leading cause of COPD, with 85% of the cases being because of this reason. The other 15% may be due to the exposure to second-hand smoke, air pollution, chest infections, and genetic disorders such as AAT deficiency. Thus, the rising smoking population is expected to increase the number of individuals with COPD, which increases the treatment-seeking population and drives the market

Further, the report states that negligence towards use of controller medications will be a major challenge for the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Request A Sample copy of This Report @

About Chronic Obstructive Pulmonary Disease (COPD)

COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.

Technavio’s analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.

The market is divided into the following segments based on geography:
• Americas

Technavio's report, Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

To Get Discount On The Report @

Connect for more details:

Sam Collins
Market Reports Center
1-646-883-3044 (US)

Market Reports Center

Sam Collins


Source: EmailWire.Com

Asia News by Country
  • North Korea
  • South Korea
  • Laos
  • Lebanon
  • Malaysia
  • Maldives
  • Mongolia
  • Nepal
  • Oman
  • Pakistan
  • Philippines
  • Qatar
  • Russia
  • Saudi Arabia
  • Singapore
  • Sri Lanka
  • Syria
  • Taiwan
  • Vietnam

  • Asia Marketplace

    Press release service Unlimited press release service

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at
    Copyright 2007 GroupWeb Media LLC
    GroupWeb Media Network

    Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | | iT-NewsWire.Com
    | i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
    AsiaNewswire.Net - Newswire and Press Release service of GroupWeb Media LLC